Entrada Therapeutics director Kush Parmar sells $1.08 million in shares — See source for full details.
$TRDA
Price history, market instrument context, member research, and related headlines in one place.
TRDA key statistics
NasdaqGMUSD
52-week range
$4.114%$16.45
Latest session $4.11–$4.77Entrada Therapeutics, Inc. (TRDA) is a stock instrument quoted on NasdaqGM in USD. The most recently published price is $4.55, down $0.31 (6.38%) from the previous close of $4.86. It has traded between $4.11 and $4.77 in the latest session. Over the past year it has ranged from $4.11 to $16.45, leaving it trading near the bottom of its 52-week range. Reported volume for the session was 740.1K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
5am Ventures V, L.P. sells $431,829 of Entrada Therapeutics stock — See source for full details.
Entrada Therapeutics earnings beat by $0.04, revenue fell short of estimates — See source for full details.
Form 4 Entrada Therapeutics Inc For: 4 August — See source for full details.
5am Ventures V sells $807,027 of Entrada Therapeutics stock — See source for full details.
Loading $TRDA research…